Biomedical Engineering Reference
In-Depth Information
Treatment 1
Treatment 2
Malignancy
Reference
Oral metronomic S-1 dosing
PEGylated Oxaliplatin Liposomes
Colorectal Cancer
[274]
PEGylated Doxorubicin Liposomes
Carboplatin
Advanced Ovarian Cancer
[275]
Liposomal doxorubicin targeted with
anti-HER2 Fab' fragments
Liposomal Vincristine with CD13-
targeted NGR peptides
HER-2 Positive Breast
Cancer
[276]
Liposomal Honokiol
Radiation h erapy
Lewis Lung Carcinoma
[277]
Temperature-sensitive liposomal
hypoxanthine followed by regional
hyperthermia
Human Colorectal and
Lung Cancer
Radiation h erapy
[278]
Bevacizumab
PEGylated liposomal doxorubicin
Recurrent Ovarian Cancer
[279]
Liposomal Curcumin
Oxaliplatin
Colorectal Cancer
[280]
Mitochondria targeted ionidamine
liposomes
Mitochondria targeted epirubicin
liposomes
Drug Resistant Lung
Cancer
[281]
Aminopeptidase A-targeted doxorubicin
liposomes
Aminopeptidase N-targeted doxorubicin
liposomes
Human Neuroblastoma
[282]
Peptide-targeted liposomal doxorubicin
selective for irradiated tumors
Radiation
Lewis Lung Carcinoma
[283]
IL-8 silencing liposomal SiRNA
Docetaxel
Ovarian Cancer
[284]
(
Continued
)
